DR. Agarwal's EYE Hosp L
NSE: DRAGARWQ · Hospital · sector
₹5,168.00NSE close 2026-10-26
Key numbers
Market cap₹2,496 cr
Price₹5,168.00
52w high / low₹6,060 / ₹4,600
P/E32.5xSector median 42.5x
P/B7.2xSector median 4.9x
Book value₹717.0
Dividend yield0.12%Sector median 0.17%
ROE27.4%Sector median 12.1%
ROCE26.1%Sector median 13.8%
OPM30.5%Sector median 20.3%
Debt / equity0.24xSector median 0.24x
EV/EBITDA16.4xSector median 23.6x
Interest cover10.7x
Current ratio1.23x
Sales growth 3y+20.7%Sector median +14.1%
Profit growth 3y+23.8%Sector median +14.7%
PEG1.40x
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹96 cr vs borrowings ₹82 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 10.7x in the last 12 months.
- Other income was 9% of net profit in the last 12 months.
- No dividend in the last 5 financial years.
- Price ₹5,168.00 on 2026-10-26: -14.7% from the 52-week high, +12.3% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹6,936.15 · low ₹3,885.85
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 100 | 117 | 118 | 116 | 120 | 143 |
| EBITDA | 32 | 37 | 40 | 34 | 34 | 43 |
| OPM % | 31.6% | 31.8% | 34.0% | 29.6% | 28.1% | 30.3% |
| Other income | 0 | 1 | 1 | 3 | 2 | 2 |
| Net profit | 16 | 17 | 19 | 17 | 16 | 23 |
| EPS (₹) | 34.02 | 36.72 | 41.04 | 35.76 | 33.60 | 48.38 |
| Revenue YoY | +20.2% | +22.3% | ||||
| Profit YoY | +1.6% | +35.5% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 201 | 268 | 319 | 397 | 471 | 497 |
| EBITDA | 58 | 75 | 91 | 118 | 145 | 151 |
| Net profit | 24 | 37 | 46 | 55 | 70 | 76 |
| EPS (₹) | 51.29 | 78.55 | 98.64 | 116.28 | 147.02 | 158.78 |
| Revenue growth | +33.1% | +19.2% | +24.4% | +18.6% | – | |
| Profit growth | +53.1% | +25.6% | +17.9% | +28.3% | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +20.7% | – | – |
| Net profit | +23.8% | – | – |
| EPS | +23.2% | – | – |
| Share price | – | – (2y) | – |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 210 | 346 |
| Borrowings | 96 | 82 |
| Cash & equivalents | 25 | 96 |
| Total assets | 613 | 766 |
| Fixed assets | 160 | 375 |
| Capital work in progress | 128 | 197 |
| Investments | 0 | 0 |
| Receivables | 14 | 19 |
| Inventory | 13 | 14 |
| Payables | 30 | 27 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 94 | 145 |
| Cash from investing | -133 | -174 |
| Cash from financing | 17 | 25 |
| Capex | 101 | 98 |
| Free cash flow | -7 | 47 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 26.1% | 20.2% |
| ROCE % | 27.5% | 24.6% |
| Debtor days | 13 | 15 |
| Inventory days | 117 | 109 |
| Payable days | 263 | 208 |
| Cash conversion cycle (days) | -133 | -84 |
| Working capital days | -29 | 20 |
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| DRAGARWQ | ₹2,496 cr | 32.5x | 7.2x | 27.4% | 26.1% | 30.5% | +20.7% | 0.12% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-09-02 | Dividend | Dividend - Rs 4 Per Share |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | DRAGARWQ |
| BSE code | 526783 |
| ISIN | INE934C01018 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = NSE close 2026-10-26.